AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 178 filers reported holding AXSOME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,702,747 | -35.3% | 510,842 | -33.4% | 0.02% | -33.3% |
| Q2 2023 | $55,152,766 | +85931.0% | 767,503 | -26.2% | 0.03% | -27.0% |
| Q1 2023 | $64,108 | -99.6% | 1,039,367 | +196.0% | 0.04% | +311.1% |
| Q3 2022 | $15,668,000 | -43.4% | 351,140 | -51.4% | 0.01% | -47.1% |
| Q2 2022 | $27,669,000 | +3685.1% | 722,451 | +3992.5% | 0.02% | – |
| Q1 2022 | $731,000 | -84.6% | 17,653 | -86.0% | 0.00% | -100.0% |
| Q4 2021 | $4,747,000 | -67.4% | 125,659 | -71.5% | 0.00% | -66.7% |
| Q3 2021 | $14,543,000 | -0.6% | 441,225 | +103.5% | 0.01% | 0.0% |
| Q2 2021 | $14,628,000 | -1.1% | 216,839 | -17.0% | 0.01% | -18.2% |
| Q1 2021 | $14,788,000 | +14.9% | 261,163 | +65.3% | 0.01% | +10.0% |
| Q4 2020 | $12,869,000 | +76.5% | 157,958 | +54.4% | 0.01% | +11.1% |
| Q3 2020 | $7,290,000 | -43.7% | 102,319 | -34.9% | 0.01% | -50.0% |
| Q2 2020 | $12,939,000 | +44.4% | 157,254 | +3.2% | 0.02% | -10.0% |
| Q1 2020 | $8,962,000 | -85.7% | 152,331 | -74.8% | 0.02% | -74.0% |
| Q4 2019 | $62,506,000 | +679.3% | 604,738 | +52.6% | 0.08% | +492.3% |
| Q3 2019 | $8,021,000 | -20.0% | 396,300 | +1.7% | 0.01% | -13.3% |
| Q2 2019 | $10,030,000 | -26.8% | 389,516 | -59.6% | 0.02% | -25.0% |
| Q1 2019 | $13,710,000 | +1474.1% | 963,474 | +212.0% | 0.02% | +1900.0% |
| Q4 2018 | $871,000 | +23.5% | 308,802 | +145.3% | 0.00% | 0.0% |
| Q4 2017 | $705,000 | -25.3% | 125,906 | -26.0% | 0.00% | 0.0% |
| Q3 2017 | $944,000 | +7.3% | 170,058 | +6.3% | 0.00% | -50.0% |
| Q2 2017 | $880,000 | +178.5% | 159,960 | +97.5% | 0.00% | +100.0% |
| Q1 2017 | $316,000 | -44.8% | 80,976 | -4.5% | 0.00% | 0.0% |
| Q4 2016 | $572,000 | +10.6% | 84,805 | +52.0% | 0.00% | 0.0% |
| Q4 2015 | $517,000 | – | 55,809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |